The first quarter with Kloeckner inside made Worthington Steel far larger and loss-making on the bottom line. The real prize, operating control through a domination agreement, is still waiting on approvals.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Comtech is selling most of its satellite and space business to an affiliate of Gilat Satellite Networks. Its new finance chief has satellite experience, which says something about how carefully the exit is being handled.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
RedHill Biopharma (Nasdaq: RDHL) used an $18 million payout from selling its stake in one drug to buy the commercial rights to two others. The Ledger traces the cash flow and asks what the strategic reset buys.
South African education group ADvTECH reported revenue of R5 060 million for the six months to 30 June 2026 and declared an interim dividend of 53.0 cents per share.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Rimfire Pacific Mining reports scandium recovery data that could point to lower capital processing at Murga, but the headline projection rests on extending 15 weeks of bottle roll results.
Safe Pro Group has given preliminary, unaudited third-quarter revenue far above last year, which it credits to U.S. defense subcontracts. The final close, and what comes after it, will show how much of that is repeatable.
Arrive AI Inc. (NASDAQ: ARAI) is launching a dedicated defense division to adapt its autonomous delivery infrastructure for military use. The company says the move could open non-dilutive government funding, but it has disclosed no contracts.
A California sales tax exclusion for a planned silicon wafer plant is real, but it is a discount on purchases not yet made, and the release says almost nothing about how those purchases will be paid for.
Astro Digital plans to go public by merging with Proem Acquisition Corp I (Nasdaq: PAAC). GSN asks whether its claims of growth and positive adjusted EBITDA can support a roughly $587 million valuation.
A Phase 3 trial of firmonertinib in an EGFR exon 20 lung cancer failed on its main independent measure while looking better on others. ArriVent now has to decide what that split result is worth.
A test-equipment maker is buying into a probe and interface specialist to speed AI-era chips to production. The deal opens several futures, and the announcement settles none of them.
CTO Realty Growth (NYSE: CTO) paid $103 million for a nearly full open-air power center near Kansas City, lifting its 2026 investment total to $439 million. GSN asks how long that pace can last and how the deal was paid for.
Nova Minerals (NYSE American: NVA) has received the final equipment for its planned Alaska antimony refinery, a project supported by a $43.4 million U.S. Department of War award. The Ledger examines what stands between delivered equipment and first antimony: permits, construction and feed.
كندا
أسهم تحت المراقبة
أسهم غير معروفة على نطاق واسع مع أخبار إنجازات بارزة، أسبوعيا.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Strategic Metals has completed a property option deal that leaves it with a significant minority stake and retained royalties in Trifecta Gold's Yukon projects.
London-based OKYO Pharma has enrolled the first patients in a Phase 3 trial for a painful eye condition with no FDA-approved treatment. The start is real. The answer is still a trial away.
American Pacific Mining (OTCQX: USGDF) is imaging hole M26C-02 at its Madison project in Montana before drilling again. The reported grades are high, but whether the zone continues beyond existing intersections is still unproven.
Prospector Metals has finished its 2026 drilling program at the Yukon ML Project with high-grade gold intercepts. The release does not say how the 2027 program will be paid for, and that is the next question.
By closing its purchase of Israeli retail media firm Hedia, A2Z Cust2Mate has bought advertiser relationships and campaign execution capabilities. The open question is whether an acquired sales team can sell A2Z's own in-store media inventory.
Comtech is selling most of its satellite and space business to an affiliate of Gilat Satellite Networks. Its new finance chief has satellite experience, which says something about how carefully the exit is being handled.
Arrive AI Inc. (NASDAQ: ARAI) is launching a dedicated defense division to adapt its autonomous delivery infrastructure for military use. The company says the move could open non-dilutive government funding, but it has disclosed no contracts.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Strategic Metals has completed a property option deal that leaves it with a significant minority stake and retained royalties in Trifecta Gold's Yukon projects.
A test-equipment maker is buying into a probe and interface specialist to speed AI-era chips to production. The deal opens several futures, and the announcement settles none of them.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
A Phase 3 trial of firmonertinib in an EGFR exon 20 lung cancer failed on its main independent measure while looking better on others. ArriVent now has to decide what that split result is worth.
Editas Medicine has cleared the hurdle to start dosing people with EDIT-401, a one-time gene edit meant to lower LDL cholesterol. The primate data are striking; the human question is entirely open.
Safe Pro Group has given preliminary, unaudited third-quarter revenue far above last year, which it credits to U.S. defense subcontracts. The final close, and what comes after it, will show how much of that is repeatable.
A Denver-based AI investor points to 124 unmanned French fuel stations as proof for its portfolio company Manako Labs. The release does not say that any of that French money reaches TaoWeave.
Rank One Computing has added biometrics scientist Dr. Anil Jain to its board, alongside an existing advisory role. GSN asks whether deep scientific expertise on the board can turn into commercial traction for its Vision AI platform.
Wolfspeed (NYSE: WOLF) has received a conditional commitment for up to $1.5 billion in financing from the U.S. Department of War. This report examines whether the capital would stabilize the silicon carbide maker or bind it to a rigid national security agenda.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Rimfire Pacific Mining reports scandium recovery data that could point to lower capital processing at Murga, but the headline projection rests on extending 15 weeks of bottle roll results.
Nova Minerals (NYSE American: NVA) has received the final equipment for its planned Alaska antimony refinery, a project supported by a $43.4 million U.S. Department of War award. The Ledger examines what stands between delivered equipment and first antimony: permits, construction and feed.
The first quarter with Kloeckner inside made Worthington Steel far larger and loss-making on the bottom line. The real prize, operating control through a domination agreement, is still waiting on approvals.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
London-based OKYO Pharma has enrolled the first patients in a Phase 3 trial for a painful eye condition with no FDA-approved treatment. The start is real. The answer is still a trial away.
American Pacific Mining (OTCQX: USGDF) is imaging hole M26C-02 at its Madison project in Montana before drilling again. The reported grades are high, but whether the zone continues beyond existing intersections is still unproven.
Prospector Metals has finished its 2026 drilling program at the Yukon ML Project with high-grade gold intercepts. The release does not say how the 2027 program will be paid for, and that is the next question.
By closing its purchase of Israeli retail media firm Hedia, A2Z Cust2Mate has bought advertiser relationships and campaign execution capabilities. The open question is whether an acquired sales team can sell A2Z's own in-store media inventory.
Blaize revised its full-year revenue range to far above its latest quarter, resting it on signed orders, inventory, suppliers and timely payment, days after announcing cuts to about a quarter of its staff.
CTO Realty Growth (NYSE: CTO) paid $103 million for a nearly full open-air power center near Kansas City, lifting its 2026 investment total to $439 million. GSN asks how long that pace can last and how the deal was paid for.
QCi's new investor deck leads with a debt-free cash pile. The open question is how much business that money is buying, and how soon customers start paying their share.
تتبع الشركات المدرجة في كينيا جدولا واحدا للإفصاح تحدده هيئة أسواق رأس المال، لكن البنوك وشركات التأمين تخضع لجهة رقابية ثانية، وهذه الطبقة الإضافية تقسم السوق إلى إيقاعين مختلفين للإفصاح.
قبل نشر النتائج المالية بأسابيع تتوقف تداولات دائرة ضيقة داخل الشركة المدرجة. شرح تعليمي لآلية سجل المطلعين وفترة الحظر والإفصاح اللاحق في السوق القطري.
بموجب قانون الأوراق المالية والعقود الآجلة في سنغافورة، يؤدي بلوغ 5% من أصوات شركة مدرجة إلى وجوب الإخطار، ثم تحدد قاعدة تقريب ما إذا كانت الصفقة التالية تستوجب الإفصاح.
الشركات المدرجة في تداول لا تطبق المعايير الدولية بصيغتها العالمية، بل نسخة معتمدة محلياً. شرح لآلية الاعتماد، وللإضافات مثل معالجة الزكاة، ولدور المراجع الخارجي ولجنة المراجعة.
شرح تعليمي لآلية بناء مؤشرات البورصة المصرية: معايير اختيار المكونات، وتعديل الأوزان بالتعويم الحر والسقف الوزني، ودور المقسوم في الحفاظ على استمرارية السلسلة الزمنية.
شرح تعليمي لآلية الإفصاح المالي الدوري في السوق القطري: تقويم القوائم الربعية والسنوية، الفرق بين الفحص المحدود والتدقيق الكامل، وترتيب وصول الأرقام إلى السوق.
بعد إتمام الطرح العام الأولي تبقى حصص كبار الملاك المذكورين في نشرة الإصدار خارج التداول ستة أشهر على الأقل. شرح لنص المادة 72، ولامتداد القيد إلى المالك النفعي والأسهم الممنوحة، ولحدود ما يقيده فعلاً.
يوزّع هيكل الصناديق المتعددة لدى «بِنكوم» كل حساب ادخار تقاعدي على صندوق يُحدَّد وفق العمر، مع سقف للأدوات ذات الدخل المتغير. وهنا آلية تحديد هذا التوزيع وتغييره.
شرح تعليمي لبنية الإدراج المزدوجة في بورصة قطر: ما الذي يميّز شروط القبول في سوق المشروعات الناشئة عن السوق الرئيسي، وكيف تُنظَّم آلية الانتقال بينهما.
يحسب مؤشر NSE 20 متوسطاً هندسياً لمكوناته بدلاً من ترجيحها بالقيمة السوقية، وهو خيار في طريقة البناء يحدد ما يمكن أن يخبر به هذا الرقم مستثمري الصناديق وما لا يمكنه.
شرح تعليمي لبنية صناديق الاستثمار العامة في السعودية: فصل مدير الصندوق عن أمين الحفظ، ودور مجلس إدارة الصندوق، وكيف يُحتسب صافي قيمة الأصول بالتسعير الآجل.
شرح تعليمي لآلية التصويت التراكمي في انتخاب مجالس إدارات الشركات المقيدة بالبورصة المصرية، وكيف تحدد معادلة حسابية بسيطة أقل نسبة من الأصوات تكفي لضمان مقعد واحد.
يعتبر قانون الاستحواذ النيجيري أن 30% من الأسهم ذات حق التصويت تعادل السيطرة. إليك كيف تُفعّل هذه العتبة عرضا إلزاميا لجميع المساهمين، وما الذي يتغير عندما يمتلك أحد المساهمين بالفعل 50%.
يخضع المؤشر المرجعي لسوق الأسهم في سنغافورة لمراجعة ربع سنوية وفق قواعد معلنة. وإليك كيف تحدد نسبة الأسهم الحرة واختبارات السيولة ونطاقات الترتيب من يدخل ومن يخرج.
شرح تعليمي لكيفية إصدار الصكوك الحكومية بالريال عبر تقويم المزادات لدى المركز الوطني لإدارة الدين والمتعاملين الأوليين، وكيف ينشأ من ذلك المرجع الذي تُسعَّر عليه ديون الشركات.
شرح تعليمي لآلية تعيين ممثل مستقل لحملة السندات والصكوك المدرجة في قطر، ولكيفية انتقال حالة الإخلال بالتعهدات من مطالبة فردية إلى قرار جماعي بأغلبية تعاقدية.
تُباع معظم سندات الشركات المقوّمة بالدولار السنغافوري بكميات تفوق كثيرًا قدرة المستثمر الفرد. آلية تُعرف بـ«التعتيق» تفسّر كيف يصبح بعضها لاحقًا متاحًا بوحدات صغيرة في بورصة سنغافورة.
شرح تعليمي للآلية التنظيمية التي تُلزم من يتجاوز نسبة محددة من حقوق التصويت في شركة مدرجة بالبورصة القطرية بتقديم عرض شراء لبقية المساهمين، ولمراحل تنفيذ هذا العرض.
شرح تفصيلي لآلية توزيع الأسهم المجانية عبر رسملة الاحتياطيات في السوق المصري، من موافقة الجمعية العامة غير العادية والهيئة العامة للرقابة المالية إلى تعديل السعر المرجعي وقيد الأسهم.